Horatiu Olteanu MD, PhD

Dr. Olteanu’s primary clinical activity is in the Hematopathology service at Froedtert Hospital, which covers morphology and flow cytometry sign-out of bone marrow and lymph node biopsies. He is also involved in medical student and pathology resident teaching, as director of Hematopathology and Flow Cytometry resident rotations, and oversees the Hematopathology fellowship.

His publications are as follows:
Cogbill CH, Spears MD, vanTuinen P, Harrington AM, Olteanu H, Kroft SH. Morphologic and cytogenetic variables affect the flow cytometric recovery of plasma cell myeloma cells in bone marrow aspirates. Int J Lab Hematol. 2015 Jul 30:.
Olteanu H, Harrington AM, Kroft SH. CD200 expression in plasma cells of nonmyeloma immunoproliferative disorders: clinicopathologic features and comparison with plasma cell myeloma. Am J Clin Pathol. 2012 Dec;138(6):867-76.
Olteanu H, Schur BC, Harrington AM, Kroft SH. Time and temperature stability of T-cell subsets evaluated by a dual-platform method. Am J Blood Res. 2012;2(2):128-35.
Olteanu H, Harrington AM, Kroft SH. Immunophenotypic stability of CD200 expression in plasma cell myeloma. Am J Clin Pathol. 2012 Jun;137(6):1013-4.
Harrington AM, Olteanu H, Kroft SH. A dissection of the CD45/side scatter "blast gate". Am J Clin Pathol. 2012 May;137(5):800-4.
Vaughan J, Harrington AM, Hari PN, Kroft SH, Olteanu H. Immunophenotypic stability of Sézary cells by flow cytometry: usefulness of flow cytometry in assessing response to and guiding alemtuzumab therapy. Am J Clin Pathol. 2012 Mar;137(3):403-11.
Horna P, Olteanu H, Kroft SH, Harrington AM. Flow cytometric analysis of surface light chain expression patterns in B-cell lymphomas using monoclonal and polyclonal antibodies. Am J Clin Pathol. 2011 Dec;136(6):954-9.